The life sciences industry is on the cusp of a major paradigm shift towards data-driven, patient-centric value chains. This new paradigm puts the needs of the patient at the center of all operations within a life sciences company and is expected to become prevalent by 2025.
In this survey, we aim to understand the priorities of LS industry decision-makers for their companies over the next three years. We also want to investigate their perspectives on the impact of digitalization on the profitability and sustainability of their businesses. Additionally, we hope to gain insight into the opportunities and challenges they anticipate soon until 2025.